R.J. Zuckerberg Cancer Center-Medical Oncology ( Site 0132) — Lake Success, New York

R.J. Zuckerberg Cancer Center-Medical Oncology ( Site 0132) is a clinical research site located in Lake Success, New York, United States 11042.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

R.J. Zuckerberg Cancer Center-Medical Oncology ( Site 0132) has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Melanoma, Carcinoma, Renal Cell.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lake Success

Browse all research sites in New York · View every site in Lake Success

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for R.J. Zuckerberg Cancer Center-Medical Oncology ( Site 0132)?

R.J. Zuckerberg Cancer Center-Medical Oncology ( Site 0132) has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has R.J. Zuckerberg Cancer Center-Medical Oncology ( Site 0132) conducted?

R.J. Zuckerberg Cancer Center-Medical Oncology ( Site 0132) has 3 clinical trials on record, with 2 currently active. Their work covers Melanoma, Carcinoma, Renal Cell.

Is R.J. Zuckerberg Cancer Center-Medical Oncology ( Site 0132) accredited by Crixeo Clinical Trials?

R.J. Zuckerberg Cancer Center-Medical Oncology ( Site 0132) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about R.J. Zuckerberg Cancer Center-Medical Oncology ( Site 0132)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.